No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
ANI Pharmaceuticals(ANIP.US) Officer Sells US$3.01 Million in Common Stock
Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why
ANI's Generic L-Glutamine Oral Powder Hits Market, Targets $20.1M Annual Sales
Express News | ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
ANI Pharmaceuticals (NASDAQ:ANIP) Shareholder Returns Have Been Decent, Earning 95% in 3 Years
ANI Pharmaceuticals(ANIP.US) Officer Sells US$1.27 Million in Common Stock